GUILLAIN-BARRE SYNDROME

EU regulator reviews reports of rare nervous disorder after AstraZeneca vaccine

EU regulator reviews reports of rare nervous disorder after AstraZeneca vaccine

Europe’s medicines regulator said on Friday it was reviewing reports of a rare condition affecting the nerves following vaccination with AstraZeneca’s Covid-19 shot, and requested the British drugmaker for more detailed data.

As part of a regular review of safety reports for the vaccine, Vaxzevria, the European Medicines Agency’s safety committee is analysing data provided on cases of Guillain-Barre syndrome, the regulator said.

AstraZeneca did not immediately respond to requests for comment. [Reuters]